Benzinga's Top Downgrades

 

  • Analysts at JP Morgan downgraded Esperion Therapeutics Inc ESPR from Overweight to Neutral. The price target for Esperion Therapeutics has been lowered from $50 to $15. Esperion Therapeutics shares fell 32.51 percent to $10.92 in pre-market trading.
  • Analysts at Wells Fargo downgraded HeartWare International Inc HTWR from Outperform to Market Perform. Heartware shares closed at $57.55 on Tuesday.
  • Goldman Sachs downgraded PBF Energy Inc PBF from Buy to Neutral. The price target for PBF Energy has been lowered from $37 to $26. PBF Energy shares slipped 0.04 percent to $23.28 in pre-market trading.
  • Analysts at Bank of America downgraded Lincoln National Corporation LNC from Buy to Neutral. Lincoln National shares rose 0.33 percent to $36.89 in pre-market trading.
  • Susquehanna downgraded COMSCORE, Inc. SCOR from Positive to Neutral. comScore shares closed at $23.83 on Tuesday.
  • Evercore ISI Group downgraded Oceaneering International OII from Buy to Hold. Oceaneering International shares closed at $28.62 on Tuesday.
  • RBC Capital downgraded Metaldyne Performance Group Inc MPG from Outperform to Sector Perform. Metaldyne Performance Group shares closed at $13.62 on Tuesday.
  • Bank of America downgraded Principal Financial Group Inc PFG from Buy to Neutral. Principal Financial shares gained 0.10 percent to $39.10 in pre-market trading.
  • Analysts at Barclays downgraded AEGON N.V. (ADR) AEG from Equal-weight to Underweight. Aegon shares fell 1.98 percent to $3.96 in pre-market trading.
Market News and Data brought to you by Benzinga APIs
Comments
Loading...
date
▲▼
ticker
▲▼
name
▲▼
Price Target
▲▼
Upside/Downside
▲▼
Recommendation
▲▼
Firm
▲▼
Posted In:
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!